Most New Drugs in South Korea See Prices Cut After Listing, Study Finds
A longitudinal analysis of South Korea's National Health Insurance data found that 75.5 percent of 212 newly listed drugs underwent ...
A longitudinal analysis of South Korea's National Health Insurance data found that 75.5 percent of 212 newly listed drugs underwent ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.